KiOmed Pharma Competitors and Similar CompaniesClear all
KiOmed Pharma's competitors and similar companies include CorMedix, Veloxis Pharmaceuticals, Neurogastrx and Hoth Therapeutics.
 KiOmed Pharma KiOmed Pharma is a company that offers chitosan-based biomaterials for the development of therapeutic medical devices. |  CorMedix CorMedix is a pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiac and kidney disease. |  Veloxis Pharmaceuticals Veloxis Pharmaceuticals is a biopharmaceutical company that identifies, develops, and commercializes products used in transplantation and adjacent therapies. |  Neurogastrx Neurogastrx is a biopharmaceutical company developing products for the treatment gastrointestinal disorders treatment. |  Hoth Therapeutics Hoth Therapeutics operates as a biopharmaceutical company that develops therapeutics for patients suffering from atopic dermatitis. | |
Founding Date | Founding Date 2012 | Founding Date 2006 | Founding Date 2002 | Founding Date 2012 | Founding Date N/A |
Type | Type Private | Type Public | Type Subsidiary | Type Private | Type Public |
Tags | |||||
Locations | Locations Herstal, BE HQ | Locations Berkeley Heights, US HQ | Locations København, DK HQ Cary, US Cary, US | Locations Woburn, US HQ | Locations New York, US HQ |
Employees | Employees 432% increase | Employees 3036% increase | Employees 54 | Employees 12 | Employees 2 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 749.2 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 6.7 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $311.7m (FY, 2025) | Revenue (est.) kr39.5m (FY, 2018) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $22.1m (FY, 2025) | Cost of goods kr7.9m (FY, 2018) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $275.7m (FY, 2025) | Gross profit kr31.6m (FY, 2018) | Gross profit N/A | Gross profit N/A |
Net income | Net income N/A | Net income $163.1m (FY, 2025) | Net income (kr5.3m) (FY, 2018) | Net income N/A | Net income ($12.5m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 11.5m | Total funding raised $ 60m | Total funding raised $ 45m | Total funding raised $ 3.7m |
For sources of this data, please see the company profile
View Company Profiles
CorMedix
HQ
Berkeley Heights, US
Employees
30↑ 36% increase
CorMedix is a pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiac and kidney disease.
View companyVeloxis Pharmaceuticals
HQ
København, DK
Veloxis Pharmaceuticals is a biopharmaceutical company that identifies, develops, and commercializes products used in transplantation and adjacent therapies.
View companyNeurogastrx
HQ
Woburn, US
Employees
12
Neurogastrx is a biopharmaceutical company developing products for the treatment gastrointestinal disorders treatment.
View companyHoth Therapeutics
HQ
New York, US
Employees
2
Hoth Therapeutics operates as a biopharmaceutical company that develops therapeutics for patients suffering from atopic dermatitis.
View company